Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Surgeons complete world’s first robotic eye operation
Surgeon using the robot
The robot operates through a single hole in the eye that is less than 1mm in diameter.

Procedure may be used to develop novel treatments for blindness

The world's first eye operation using a robot has been successfully completed at Oxford's John Radcliffe Hospital.

Surgeons remotely controlled the robot to lift a membrane 100th of a millimetre thick from the retina at the back of an eye.

Patient Dr William Bever is the first person to ever undergo the experimental procedure and said that his sight "is coming back".

Surgeons hope the procedure will eventually be used to develop novel treatments for blindness that are not possible with the human hand.

"There is no doubt in my mind that we have just witnessed a vision of eye surgery in the future," said Professor Robert MacLaren, who led the surgery.

The robot operates through a single hole in the eye that is less than 1mm in diameter. It is designed to eliminate unwanted tremors in the surgeon's hand - such as through their pulse - so tiny manipulations can be carried out safely.

Surgeons control the robot with a joystick and touchscreen outside the eye. This gives them a notable advantage as significant movements of the joystick result in tiny movements of the robot.

While robots have been developed for the large-scale surgery, this is the first time a device has been available that achieves the three dimensional precision required to operate inside the human eye.

"Current technology with laser scanners and microscopes allows us to monitor retinal diseases at the microscopic level, but the things we see are beyond the physiological limit of what the human hand can operate on," explains Professor MacLaren.

"With a robotic system, we open up a whole new chapter of eye operations that currently cannot be performed."

Speaking at his follow up visit at the Oxford Eye Hospital, Dr Beaver said: "My sight is coming back. I am delighted that my surgery went so well and I feel honoured to be part of this pioneering research project."

Professor MacLaren added: "This will help to develop novel surgical treatments for blindness, such as gene therapy and stem cells, which need to be inserted under the retina with a high degree of precision."

Image (C) Oxford University Hospitals

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.